Anisotropine Methylbromide

CHEMBL1578 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
362.3 g/mol
LogP
Phase
4

The methylbromide quaternary ammonium salt of anisotropine, an anticholinergic drug used to reduce gastrointestinal spasms by blocking muscarinic receptors. This salt form limits absorption from the gut, concentrating effects locally.

Berat Molekul

362,3000 g/mol

TPSA

26,30 Ų

Mekanisme Kerja

Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanisme

Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCC(CCC)C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]2(C)C.[Br-]

InChI

InChI=1S/C17H32NO2.BrH/c1-5-7-13(8-6-2)17(19)20-16-11-14-9-10-15(12-16)18(14,3)4;/h13-16H,5-12H2,1-4H3;1H/q+1;/p-1/t14-,15+,16+;

Molecular Formula

C17H32BrNO2

HBD / HBA

- / 3

Ikatan yang Dapat Dirotasi

7

Atom Berat

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

The methylbromide quaternary ammonium salt of anisotropine, an anticholinergic drug used to reduce gastrointestinal spasms by blocking muscarinic receptors. This salt form limits absorption from the gut, concentrating effects locally.

Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.

Yes, Anisotropine Methylbromide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1578. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 657201. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.